Division of Cardiovascular Medicine, Department of Medicine.
Department of Medicine.
J Hypertens. 2024 Nov 1;42(11):1994-2002. doi: 10.1097/HJH.0000000000003835. Epub 2024 Aug 9.
BACKGROUND/OBJECTIVE: Hypertensive disorders of pregnancy (HDP) are a major cause of maternal morbidity and mortality in the US. Improved diagnosis and treatment of HDP may be achieved through home blood pressure monitoring (HBPM). However, there are challenges to effective HBPM during pregnancy. This qualitative study was conducted to explore patients' perspectives and experiences with HBPM.
Pregnant or recently postpartum women with HDP (≥18 years) were recruited from an academic medical center to virtual focus groups from March to September 2023. The discussions centered on experiences with HDP and barriers and facilitators to HBPM. Qualitative thematic analysis was performed.
Among 20 participants, the mean age was 33.8 (SD 5.9) years, with 35% Hispanic and 35% Black/African-American. Facilitators to HBPM included understanding the parameters/purpose of HBPM, prior experience with healthcare/duration of hypertension, free access to HBPM equipment and decision support, creating a routine, external support/counseling (e.g., partner/healthcare/family), and technology support. Barriers to HBPM included uncertainty/lack of training about the HBPM process, accessing/using HBPM equipment, the belief that clinic monitoring was sufficient/achieving good control, and activation barriers to making HBPM a priority (e.g., fear of affirming the diagnosis, higher priorities/life stressors).
Many of the barriers to HBPM in pregnancy can be overcome through patient education/counseling, technology support, clinician/family reinforcement, and better access to validated blood pressure monitors. Given the importance of HBPM in improving outcomes for HDP, it is important for healthcare providers and policy makers to work to reduce barriers and amplify facilitators to HBPM for better adoption.
背景/目的:妊娠高血压疾病(HDP)是美国产妇发病率和死亡率的主要原因。通过家庭血压监测(HBPM)可以提高 HDP 的诊断和治疗效果。然而,在妊娠期间进行有效的 HBPM 存在挑战。本定性研究旨在探讨患者对 HBPM 的看法和经验。
从 2023 年 3 月至 9 月,从一家学术医疗中心招募患有 HDP(≥18 岁)的孕妇或近期产后妇女参加虚拟焦点小组。讨论集中在 HDP 的经验以及 HBPM 的障碍和促进因素上。采用定性主题分析。
在 20 名参与者中,平均年龄为 33.8(SD 5.9)岁,35%为西班牙裔,35%为黑人和非裔美国人。HBPM 的促进因素包括了解 HBPM 的参数/目的、之前的医疗保健经验/高血压持续时间、免费获得 HBPM 设备和决策支持、建立常规、外部支持/咨询(如伴侣/医疗/家庭)和技术支持。HBPM 的障碍包括对 HBPM 过程缺乏培训/不确定、获取/使用 HBPM 设备、认为诊所监测已足够/达到良好控制、以及将 HBPM 作为优先事项的激活障碍(例如,担心确认诊断、更高的优先级/生活压力)。
通过患者教育/咨询、技术支持、临床医生/家庭支持以及更好地获得经过验证的血压监测仪,可以克服妊娠期间 HBPM 的许多障碍。鉴于 HBPM 在改善 HDP 结局方面的重要性,医疗保健提供者和政策制定者应努力减少 HBPM 的障碍,增强其促进因素,以促进更好的采用。